Preliminary Criteria Not Met

Thank you for your interest in the IDCT trial and for completing this questionnaire. Unfortunately, based on your responses, you do not meet the pre-screening criteria for participation in the study.

Prior to beginning this clinical study, DiscGenics worked closely with the U.S. Food and Drug Administration (FDA) to define a set list of enrollment criteria that would enable us to most effectively and efficiently evaluate the safety and preliminary efficacy of IDCT for the treatment of degenerative disc disease. This requires us to follow very specific pre-screening guidelines to ensure that the individuals enrolled in our study meet the criteria we agreed upon with the FDA. 

We appreciate your understanding and invite you to visit the following website for a complete list of inclusion and exclusion criteria:


The DiscGenics Clinical Affairs Team